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Abstract
Chronic obstructive pulmonary disease (COPD) kills approximately 2.8 million people each year, and more than 80% of
COPD cases can be attributed to smoking. Leukocytes recruited to the lung contribute to COPD pathology by releasing
reactive oxygen metabolites and proteolytic enzymes. In this work, we investigated where leukocytes enter the lung in the
early stages of COPD in order to better understand their effect as a contributor to the development of COPD. We
simultaneously evaluated the parenchyma and airways for neutrophil accumulation, as well as increases in the adhesion
molecules and chemokines that cause leukocyte recruitment in the early stages of tobacco smoke induced lung disease. We
found neutrophil accumulation and increased expression of adhesion molecules and chemokines in the bronchial blood
vessels that correlated with the accumulation of leukocytes recovered from the lung. The expression of adhesion molecules
and chemokines in other vascular beds did not correlate with leukocytes recovered in bronchoalveolar lavage fluid (BALF).
These data strongly suggest leukocytes are recruited in large measure through the bronchial circulation in response to
tobacco smoke. Our findings have important implications for understanding the etiology of COPD and suggest that
pharmaceuticals designed to reduce leukocyte recruitment through the bronchial circulation may be a potential therapy to
treat COPD.
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Introduction
Chronic obstructive pulmonary disease (COPD) is the fourth
leading cause of death in the United States [1], and 80–90% of
COPD cases can be attributed to smoking [2]. COPD is
characterized by airflow limitation presented as either chronic
bronchitis, emphysema or both. Chronic bronchitis is distinguished
by excessive mucous production, airway wall thickening, epithelial
squamous metaplasia, and leukocyte recruitment to airway walls
[3]. Emphysema is characterized by airspace enlargement and
parenchymal destruction [4].
Leukocytes recruited to the lung in response to tobacco smoke
contribute to the development of both airway and alveolar
manifestations of COPD by releasing reactive oxygen metabolites
and proteolytic enzymes. Positive feedback loops are triggered that
perpetuate leukocyte recruitment, subsequent airway epithelial
damage and airspace enlargement after smoking cessation [5].
Leukocytes are recruited to inflamed tissues via adhesion molecule
and chemokine expression when an acute inflammatory stimulus
triggers increased adhesion molecule and chemokine expression by
vascular endothelial cells and adjacent tissue. Adhesion molecules
act by capturing leukocytes from the blood stream. Chemokines
facilitate transmigration of leukocytes out of the blood vessels and
to the inflamed tissue [6].
The location of leukocyte emigration into the lung in response to
tobacco-smoke is unknown. However, some evidence from smoke-
induced COPD suggests that the bronchial blood vessels may play a
role in leukocyte recruitment. Bronchial biopsies from COPD
patients have demonstrated increased E-selectin, ICAM, IL-8 and
MCP-1 in the bronchial blood vessels or submucosa [7–10].
In this work, we used a spontaneously hypertensive (SH) rat
model of COPD to investigate the mechanism and location of
smoke-induced leukocyte recruitment to the lung.
Materials and Methods
Animals
Twelve-week-old male SH rats were purchased from Charles
River Laboratories (Portage, MI). Upon arrival, all animals were
housed in polycarbonate cages under a 12-hour light-dark cycle
with continuous access to food and water. Animals were
acclimated to the new housing environment for one week before
tobacco smoke exposure began. All animals were handled
according to the U.S. Animal Welfare Acts, and all procedures
were performed under the supervision of the University Animal
Care and Use Committee (University of California, Davis,
protocol number 15956). Two animals from the 4 week smoke
exposure group and one rat from the 12 week smoke exposure
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group were removed from the study due to lethargy and significant
weight loss.
Tobacco Smoke Exposure
Groups of 6 SH rats each were exposed to filtered air or to
tobacco smoke at a concentration of approximately 80–90 mg/m3
total suspended particulates (TSP) for 6 hours/day, 3 days/week,
for either 3 days, 4 weeks, or 12 weeks. A total of four experiments
were performed: two three-day exposures, one four-week exposure
and one twelve-week exposure. To increase the power and make
this study possible we utilize two three day smoke exposure studies.
The two three-day exposure experiments were designed as a 262
factorial to evaluate two binary factors, tobacco smoke (TS) vs.
filtered air (FA) and soluble epoxide hydrolase inhibitor (sEHI) vs.
no drug, with 6 animals per cell. Treatment with the drug had no
effect on leukocyte recruitment or adhesion molecule expression
[11]. Whole body exposure to cigarette smoke was done using a
TE10 smoke exposure system [12] that combusts 3R4F research
cigarettes (Tobacco and Health Research Institute, University of
Kentucky, KY) with a 35 ml puff volume of 2 seconds duration,
once each minute following the Federal Trade Commission
smoking standard. In addition to TSP, exposure conditions were
monitored daily for both nicotine and carbon monoxide
concentrations.
Tissue Preparation
SH rats were anesthetized with an overdose of sodium
pentobarbital 18–20 hours following the final day of exposure
with the exception of one of the 3-day studies in which the rats
were sacrificed 1–3 hours post-exposure. The trachea was
cannulated, the left lung bronchus tied, and the right lung lavaged
with Ca2+/Mg2+-free phosphate buffered saline (PBS) (pH 7.4) or
Hank’s buffered salt solution (HBSS) with a volume calculated
from the body weight, according to the equation of 35 ml/kg body
weight 62/3 of filtered air control rats. Bronchoalveolar lavage
(BAL) was performed using a three-in/three-out pattern of
intratracheal instillation and removal with the same PBS aliquot
in order to enrich total cell and protein recovery. BAL fluid
(BALF) was collected in tubes and kept on ice prior to processing.
The lavaged lung lobes were frozen in liquid nitrogen and stored
at 280uC until use. For histology, the suture on the left lung
bronchus was released and the lung was inflated with 4%
paraformaldehyde at 30 cm water pressure for 1 hour, followed
by storage of the inflation-fixed lung immersed in fixative.
BALF Analysis
The BALF was centrifuged at 2506g for 10 minutes at 4uC to
separate cells from the supernatant fluid (16). After centrifugation,
the cell pellet was resuspended in Ca2+/Mg2+-free PBS or HBSS.
The cell suspension was assayed for cell viability as determined by
trypan blue exclusion. Total cell number was determined using a
hemocytometer. Cytospin slides (Shandon, Pittsburgh, PA) were
prepared using aliquots of cell suspension that were then stained with
Hema 3 (Fisher Scientific, Pittsburgh, PA). Cell differentials in BALF
were assessed by counting macrophages, neutrophils, lymphocytes,
and eosinophils on cytocentrifuge slides using light microscopy (over
500 cells counted per sample). The proportion of each cell type was
multiplied by the total cell number per ml to determine total
neutrophils, macrophages, lymphocytes and eosinophils per ml.
Immunohistochemistry
Immunohistochemistry was performed using transverse lung
tissue slices containing the first and second intrapulmonary airway
generations. Five micron thick sections were cut from paraffin-
embedded tissue blocks on a microtome. Sections were placed on
glass slides and baked overnight at 37uC. Sections were
subsequently deparaffinized in toluene and hydrated through a
graded series of alcohol. Antigen retrieval consisted of heat
treatment by decloaker (123uC for 2 min and 83uC for 10 sec,
Decloaking Chamber, Biocare Medical, Concord, CA) with
sections in EDTA (pH 8, IHC Select). Incubation with primary
antibodies was for one hour for all sections. Goat anti-rat ICAM
(0.01 mg/ml), VCAM (0.1 mg/ml), and E-selectin (0.1 mg/ml)
antibodies (R&D Systems, Minneapolis, MN) and rabbit anti-rat
MCP-I (0.1 mg/ml) and MIP-2 (0.01 mg/ml) antibodies (Abcam,
Cambridge, MA) were used as primary antibodies. The following
was used for antibody visualization: 1) biotinylated anti-Goat IgG
(Vector BA5000, Burlingame, CA) Liquid DAB+Substrate Chro-
mogen System (Dako K3468, Carpinteria, CA) for rabbit anti-rat
antibodies, 2) biotinylated anti-Goat IgG (Vector BA5000) with
HRP Streptavidin (Zymed 50-209Z, South San Francisco, CA) for
goat anti-rat antibodies, and 3) Liquid DAB+Substrate (Dako
K3468) for both antibody types. Sections were then hematoxylin
counterstained, dehydrated in ethanols and mounted with Clear
Mount (American Tech Master Scientific, Inc., Lodi, CA). For
hematoxylin and eosin staining, sections were stained with the
following American Master Tech Scientific materials: Harris
Hematoxylin, Differentiating Solution, Bluing Solution, and Eosin
Y Stain.
For immunohistochemical data analysis, the entire lung tissue
section composed of airways, blood vessels, parenchyma and
pleura was evaluated for each animal by a blinded observer for
adhesion molecule or chemokine staining with two different
concentrations of antibody. Staining intensities that had unam-
biguous cellular labeling at either antibody concentration were
evaluated at the airway (proximal and distal), pulmonary artery
and vein, lung parenchyma and pleura. In locations where staining
differences could be determined, a score of zero was given to the
rat with the least staining and a score of five was given to the rat
with the most prominent staining based on both the frequency and
intensity of staining at each anatomical location. In a 40%
subsample that was also scored by a second blinded observer,
inter-rater reliability was estimated to be 94%. This technique
made it possible to analyze the complete tissue section for changes
in expression in multiple locations simultaneously.
Bronchial blood vessel neovasculazation
Bronchial blood vessels were counted in hematoxylin and eosin
stained slides and reported as blood vessels per mm airway. The
circumference of airways was measured with Image J software.
Mean linear intercept
Non-overlapping fields of hematoxylin and eosin stained
sections consisting of only alveolar tissues (i.e., alveolar ducts and
alveoli) were captured. The volume fraction (Vv) of alveoli and
alveolar ducts were determined by point counting using the
formula: Vv= Pp=Pn/Pt where Pp is the point fraction of Pn, the
number of test points hitting the structure of interest, divided by Pt,
the total points hitting the reference space (parenchyma). In
addition, the mean linear intercept (MLI) length of the alveolar
airspace was determined by counting the number of intercepts a
random test line of known length made with alveolar septa. MLI is
expressed as the average length of the line between intercepts.
Statistical analysis
Duration-specific (3 day, 4-week and 12-week) contrasts in
mean levels of study outcomes between tobacco-smoke and filter-
Leukocyte Recruitment via Bronch. BV in COPD Model
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air exposed rats were assessed and compared by fitting ANOVA or
regression models that included main effects for smoking and
duration and interaction terms for duration and smoking. To
minimize confounding due to the additional complexity of the two
three-day experiments, a variety of approaches were used. For the
mean linear intercept outcome, the analysis was restricted to just
the non-drug exposed animals from studies with the 18–20 hour
post-exposure sacrifice interval. For comparing mean levels of the
other outcomes, ANOVA/regression models included indepen-
dent binary indicator variables for the drug factor (coded ‘1’ if
exposed to sEHI and ‘0’ otherwise) and for experiment factor
(coded ‘1’ for the 3-day experiment with the shorter post-exposure
sacrifice interval and ‘0’ otherwise), to statistically adjust for
variation due to these two nuisance factors.
To estimate and compare the role of different vascular bed
locations on leukocyte recruitment, we correlated location-specific
smoke-induced adhesion molecule and chemokine expression
levels with numbers of leukocytes recovered in the BALF. Animals
from the smoke-exposed groups in both experiments with three
day exposure durations were analyzed together to increase the
power of this analysis. To statistically adjust for extraneous
variation due to between-experiment effects and to the drug factor
in the 3-day experiments, adhesion molecule and chemokine
expression scores were rank-transformed within blocks defined by
unique combinations of experiment and drug exposure for these
correlation analyses [13]. The Spearman correlation of the smoke-
induced adjusted ranks of adhesion molecule or chemokine
expression at each location with adjusted ranks of leukocytes and
neutrophils recovered in the BALF is reported.
To assess and compare the effects of smoke exposures of various
durations on blood cell counts and on adhesion molecule and
chemokine expression levels in or around the bronchial blood
vessels, mean levels of outcomes were compared using analysis of
variance methods [14]. Blood cell counts were log-transformed to
reduce skewness and analyzed using ANOVA models as described
above. For each blood cell count outcome, separate models were
specified for the 3-day exposure experiments and for the
remainder of the data. To account for the non-normality of each
expression level outcome, the data from all of the experiments
were pooled, rank-transformed and then analysed in a single
model, with the statistical significance of the duration specific
smoking vs. filtered contrasts (and between-duration comparisons
of these contrasts) assessed using permutation tests in order to
ensure the robustness and validity of our inferences [15]. A Monte
Carlo approximation (based on 13,000 replications) to the
permutation distribution was generated by randomly permuting
the smoking factor within blocks defined by the combination of
study and drug exposure using the standard re-sampling
procedures available in Stata (StataCorp LP, College Station,
Texas). Sensitivity analyses were also conducted to verify that
conclusions were not substantively affected by methods used to
account for the more complex 3-day experimental data.
Results
Cigarette smoke induces extensive damage to the
bronchial epithelium
Exposure of rats to smoke for 3 days caused extensive damage to
the bronchial airway epithelium that was associated with epithelial
cell death and sloughing as well as neutrophil infiltration of the
bronchial wall and epithelium in the absence of notable edema
(Figure 1). There was no obvious cell death and no increase in
neutrophil infiltration within the alveolar parenchyma. After 4
weeks of tobacco smoke exposure, there were extensive areas of
squamous epithelial metaplasia along the central bronchial airway.
In addition, more distal airways demonstrated an abundance of
goblet cells lining the luminal surface and increased cellularity
within the airway wall, including the presence of neutrophils and
accumulation of macrophages and neutrophils within the lumen of
the airways frequently enmeshed in a thick mucous lining. Some
mucous secretions were also observed to extend down into the
alveolar airspace; however, this may be due to fixative pushing
mucous from the airway to the parenchyma. After 12 weeks of
smoke exposure, there were large areas of keratinizing, stratified
squamous epithelium and infiltration of neutrophils in the
bronchial airways. Mucous secretions continued to be found to
extend into the alveolar airspace, and occasional alveolar ducts
showed marked distension. Airspace enlargement was measured
by mean linear intercept. Consistent with the pathology observed
in the hematoxylin and eosin staining, there was no increase in
airspace enlargement after 3 days of smoke exposure compared to
filtered air (3-day TS vs. FA contrast in mean MLI=1.7; 95%
CI=29.8 to 13.3; p = 0.77). However, there were significant
increases in airspace enlargement after 4 and 12 weeks of tobacco
smoke exposure (Figure 2) compared to control (4-week con-
trast = 28.9; 95% CI= 16.6 to 41.2; p,0.001; 12-week con-
trast = 24.7; 95% CI= 13.2 to 36.2; p,0.001). Tobacco-smoke
versus filtered air contrasts are statistically significantly different
between durations of exposure (p,0.01 for F-test of duration X
smoke interaction). The mean linear intercept was increased in the
12 week experiment as compared to the 4 week and 3 day
experiments independent of smoke exposure. For example, among
filtered air exposed animals, the difference in mean linear intercept
between 12-week versus 4-week exposed animals is 31.1 (95%
CI= 20.1 to 42.1; p,0.001).
Leukocytes are recruited to the lung following acute
tobacco smoke exposure
To determine which blood vessels facilitate leukocyte emigra-
tion from the blood into the lung, we first confirmed that acute
exposure to tobacco smoke increased leukocyte recruitment to the
lung. Following three days of smoke exposure geometric mean
(95% CI) concentrations (cell count per ml) of total leukocytes and
neutrophils recovered from bronchoalveolar lavage fluid (BALF)
were 11.96104 (8.36104 to 17.26104) and 5.36104 (3.16104 to
9.26104), respectively, and were significantly increased compared
to the geometric mean (95% CI) concentrations observed in
filtered air exposed rats 3.26104 (2.76104 to 3.96104) leukocytes
per ml and 0.156104 (0.116104 to 0.196104) neutrophils per ml.
Increased adhesion molecule and chemokine expression
in the bronchial blood vessels following acute tobacco
smoke exposure
Using immunohistochemistry, we analyzed the lung for
increased expression of adhesion molecules and chemokines that
facilitate leukocyte emigration following 3 days of tobacco smoke
exposure. Expression of the adhesion molecules E-selectin,
VCAM, and ICAM and the chemokines MCP-1 and MIP-2 were
evaluated and found expressed in site-specific regions of the lung
(Figures 3 and 4). E-selectin and VCAM expression was
significantly increased in the bronchial blood vessels and
pulmonary blood vessels of the parenchyma following tobacco
smoke exposure (Figure 3). ICAM was also found significantly
increased in the bronchial blood vessels (Figure 3) but changes in
the parenchyma blood vessels were not detected (data not shown).
Tobacco smoke-induced increases in the expression of MCP-1 and
MIP-2 were detected in the vicinity of the bronchial wall. MCP-1
Leukocyte Recruitment via Bronch. BV in COPD Model
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was significantly increased in bronchial blood vessels, and MIP-2
was significantly increased in the epithelium and macrophages of
the bronchial wall (Figure 4). On the other hand, alveolar
macrophages had decreased MIP-2 expression following tobacco
smoke exposure. Somewhat surprisingly, there was no detection of
smoke-induced expression of the adhesion molecules or chemo-
kines in the alveolar capillaries, and no detectable increases in the
expression of the adhesion molecules or chemokines were observed
in the pulmonary artery, large pulmonary vein adjacent to the
bronchus, or pleura (results not shown).
To determine if the smoke induced increases in adhesion
molecule and chemokine expression at a location are responsible
for leukocyte recruitment to the lung we correlated expression
scores after 3-days of smoke exposure with the number of
leukocytes recovered in the BALF. E-selectin, ICAM and MCP-1
in the bronchial blood vessels and MIP-2 expression in
mononuclear cells within the bronchial wall significantly correlat-
ed with total leukocytes (Table 1) and neutrophils recovered from
BALF (Table 2). The majority of the leukocytes recruited to the
lung in response to 3 days of tobacco smoke were neutrophils. The
Figure 1. Tobacco smoke induced damage to the lung. Cigarette smoke-induced damage was evaluated in hematoxylin stained lung tissue
sections (top). Cigarette smoke-induced neutrophil infiltration was evaluated using myeloperoxidase staining of lung tissue sections to confirm the
location of neutrophils in the vasculature and lung tissues (bottom). Tissue sections are from SH rats exposed to 6 hours of tobacco smoke per day
for 3 days, 4 weeks or 12 weeks.
doi:10.1371/journal.pone.0033304.g001
Figure 2. Mean linear intercept. Mean linear intercept is reported as
a measurement of alveolar airspace enlargement within the lung
parenchyma after 3 days, 4 weeks or 12 weeks of filtered air or tobacco
smoke exposure.
doi:10.1371/journal.pone.0033304.g002
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correlation of the bronchial expression of E-selectin, ICAM, and
MIP-2, which are known to cause leukocyte recruitment, strongly
suggests that the majority of leukocytes are recruited from the
bronchial blood vessels during the early stages of this tobacco
smoke induced model of COPD.
Tobacco smoke increases the vascularization of the
bronchial wall
Bronchial blood vessels in hematoxylin and eosin stained sections
were quantified. Compared to filtered air controls, tobacco smoke
exposure significantly increases the concentration (#/mm airway)
of bronchial blood vessels in the bronchial walls after 3 days of
exposure and after 4 weeks exposure, but not after 12 weeks
exposure (Figure 5). Between-duration comparisons of the duration-
specific contrasts were not statistically significant, however.
Increases in leukocyte recruitment, adhesion molecule
expression and chemokine expression diminish with long
term smoke exposure
Total leukocytes, neutrophils, and macrophages were measured
in BALF following 3 days, 4 weeks and 12 weeks of tobacco smoke
Figure 3. Tobacco smoke induced adhesion molecule expres-
sion. Top) Representative pictures of immunohistochemical (IHC)
staining of E-selectin, VCAM, and ICAM in the bronchial wall of SH
rats exposed to filtered air or 3 days of tobacco smoke. Arrows indicate
bronchial blood vessels. Bottom) IHC staining intensity of the adhesion
molecules E-selectin, VCAM, and ICAM after 3 days of tobacco smoke as
scored by blinded ranking. Br BV: bronchial blood vessel; Par BV:
parenchymal blood vessel. Brackets indicate comparisons between
filtered air exposure and tobacco smoke exposure. (Note: Adhesion
molecules and chemokine staining scores were reranked putting them
on a 1–12 scale. See methods).
doi:10.1371/journal.pone.0033304.g003
Figure 4. Tobacco smoke induced chemokine expression. Top)
Representative pictures of immunohistochemical (IHC) staining of MCP-
1 and MIP-2 in the bronchial wall of SH rats exposed to filtered air or 3
days of tobacco smoke. Bottom) IHC staining intensity of the
chemokines MCP-1 and MIP-2 after 3 days of tobacco smoke as scored
by blinded ranking. Br BV: bronchial blood vessel; Br Epi: bronchial
epithelial cells; Alv. Mac: alveolar macrophages; Br Mac: macrophages in
the bronchial wall. Brackets indicate comparisons between filtered air
exposure and tobacco smoke exposure. (Note: Adhesion molecules and
chemokine staining scores were reranked putting them on a 1–12 scale.
See methods).
doi:10.1371/journal.pone.0033304.g004
Table 1. Adhesion molecule and chemokine expression at
specific locations correlate with leukocytes recovered from
the BALF.
Adhesion
molecule correlation coef
location rho (95% CI) p value
ICAM Bronch. BV 0.55 (0.31–0.80) ,0.001*
E-Selectin Bronch. BV 0.54 (0.21–0.86) 0.001*
E-Selectin Paren. BV 0.10 (20.26–0.47) 0.6
VCAM Bronch. BV 0.05 (20.35–0.45) 0.8
VCAM Paren. BV 0.15 (20.26–0.57) 0.5
MCP-1 Bronch. BV 0.36 (0.03–0.69) 0.03*
MCP-1 Bronch. EC 0.18 (20.18–0.56) 0.3
MIP-2 Alveolar Mac 20.34 (20.69–0.004) 0.053
MIP-2 Bronch. EC 20.04 (20.44–0.36) 0.9
MIP-2 Bronch. Mon 0.41 (0.12–0.70) 0.006*
doi:10.1371/journal.pone.0033304.t001
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exposure. Compared to filtered air exposure of similar duration, 3
days (see previous result sections) and 4 weeks of tobacco smoke
exposure resulted in significantly increased total leukocytes
recovered from BALF (Figure 6). However, there was no
significant difference in total BALF leukocytes between animals
exposed to filtered air and tobacco smoke after 12 weeks of
exposure. The effect of tobacco smoke vs filtered air was
statistically significantly different at 12 weeks versus 4-weeks (F-
ratio for interaction= 6.28; p = 0.02). Compared to rats exposed to
filtered air, rats exposed to tobacco smoke had significantly more
neutrophils in BALF at all time points. The magnitudes of the
tobacco smoke effect were not statistically different at 4-weeks
compared to 12-weeks, however.. Macrophages recovered from
BALF were similar to total leukocytes, being significantly increased
after 3 days and at 4 weeks of tobacco smoke exposure but not
after 12 weeks (and with the 4-week TS vs. FA contrast
significantly different from the 12-week contrast, by the F-test).
Lymphocytes made up less than 2% of the total cells and were
increased by tobacco smoke at 4-weeks, but not at 12-weeks.
(Figure 6).
We also evaluated adhesion molecule and chemokine expression
in the bronchial blood vessels after 3 days, 4 weeks and 12 weeks of
tobacco smoke exposure. Tobacco-smoke versus filtered air
contrasts in E-selectin, VCAM and MCP-1 expression levels in
the bronchial blood vessels were statistically significant at 3 days
and at 4 weeks, but not at 12 weeks. The comparison of the 3-day
and the 12-week contrasts was statistically significant for each of
these outcomes. Immunohistochemical staining of E-selectin at 3
days, 4 weeks and 12 weeks is shown in Figure 7 (top), with the
staining scores of the other adhesion molecules and chemokines in
or around the bronchial blood vessels shown at the bottom of
Figure 7.
Discussion
We find that acute tobacco smoke exposure causes neutrophil
accumulation and increased expression of adhesion molecules and
chemokines in the bronchial blood vessels. This increased
expression of adhesion molecules and chemokines correlated with
the accumulation of leukocytes recovered from the lung. The
expression of adhesion molecules and chemokines in other
vascular beds did not correlate with leukocytes recovered in
BALF. These findings suggest that leukocytes are recruited
primarily through the bronchial circulation in response to tobacco
smoke in a rat model of COPD.
The respiratory system is unique compared to other organ
systems because it utilizes both classical and alternative mecha-
nisms to recruit leukocytes [16–19]. In the classic model of
leukocyte recruitment, an acute inflammatory stimulus triggers
increased adhesion molecule and chemokine expression by
vascular endothelial cells and adjacent tissue that facilitates
leukocyte adhesion and subsequent migration into the inflamed
tissue. Selectin family adhesion molecules expressed on activated
vascular endothelial cells assist with the initial capture of
leukocytes from the blood stream by tethering, after which
leukocytes roll along the vascular endothelium via transient bonds
with selectins and IgG family adhesion molecules, including
ICAM and VCAM. As the leukocytes roll, chemokines, such as
MCP-1 and IL-8 (MIP-2 in rats), released by the vascular
endothelial cells and surrounding tissues activate the leukocytes,
resulting in their increased binding affinity to ICAM and/or
VCAM. The increased leukocyte binding affinity for ICAM and/
or VCAM facilitates the arrest and eventual transmigration of
leukocytes through blood vessels. Leukocytes continue to migrate,
following a chemokine concentration gradient to regions of
inflamed lung tissue (reviewed by Malik et al. [6]).
The alternative mechanism of leukocyte recruitment occurs in
the alveolar capillaries via a unique mechanism that is indepen-
dent of selectins and ICAM. During an acute inflammatory event,
the majority of pulmonary leukocytes are in alveolar capillaries.
This is likely due to the small size of the alveolar capillaries slowing
the passage and increasing the concentration of neutrophils to 35–
100 times greater in alveolar capillaries than in the systemic
circulation. The narrow passages of the alveolar capillaries
eliminate the need for neutrophil capture by adhesion molecules.
Several studies using bacteria or bacterial products or acid
instillation have demonstrated ICAM and/or E-selectin-indepen-
dent transmigration of leukocytes [20–25], suggesting that in
general, leukocytes extravasate from the alveolar capillaries during
an inflammatory response.
Results from this study indicate that leukocytes are being
classically recruited through the bronchial blood vessels in
response to tobacco smoke exposure because the time points with
the greatest increase in BALF leukocytes are the time points with
the greatest adhesion molecule/chemokine expression in the
bronchial blood vessels. After a 12-week smoke exposure, rats
had significant increases in total leukocytes in BALF, but the
increase was much less robust as compared to after a 3-day smoke
exposure. Furthermore, adhesion molecule and chemokine
expression in or around the bronchial blood vessels of the 12
week exposure group was generally increased, but to a lesser extent
than following the 3 day exposure group. This further supports the
Table 2. Neutrophil specific adhesion molecule and
chemokine expression at specific locations correlate with
neutrophils recovered from the BALF.
Adhesion molecule correlation coef
location rho (95% CI) p value
ICAM Bronch. BV 0.57 (0.35–0.80) ,0.001*
E-Selectin Bronch. BV 0.45 (0.10–0.80) 0.012*
E-Selectin Paren. BV 0.31 (20.05–0.67) 0.09
MIP-2 Alveolar Mac 20.34 (20.68–0.01) 0.054
MIP-2 Bronch. EC 0.10 (20.27–0.46) 0.593
MIP-2 Bronch. Mon 0.63 (0.43–0.84) ,0.001*
doi:10.1371/journal.pone.0033304.t002
Figure 5. Smoke increases neovasculization. Bronchial blood
vessels per mm airway lumen at 3 days, 4 weeks and 12 weeks smoke
exposure.
doi:10.1371/journal.pone.0033304.g005
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concept that bronchial blood vessels are a major contributor to
leukocyte extravasation in response to tobacco smoke during the
acute or initial genesis of the COPD process as well as during all
stages of COPD progression. These findings suggest that unlike
other lung inflammatory stimuli, leukocytes are recruited primarily
through the bronchial circulation in response to tobacco smoke.
Several studies have demonstrated alveolar capillary recruitment in
response to systemic inflammation or intralobular instillation that
delivers inflammatory stimuli closer or deeper to the alveolar region
[20–25]. We find that tobacco smoke causes initial damage in the
bronchial epithelium with the greatest changes noted in the
proximal or central airways. We have further noted leukocytes
appear to be emigrating from those blood vessels in the bronchial
walls of these central airways (Figure 1). It is not surprising that
tobacco smoke extensively injures the bronchial epithelium, since it
is the first tissue that the smoke encounters in the lower respiratory
tract. Likewise, since injury triggering the release of inflammatory
mediators leads to increased expression of adhesion molecules and
chemokines [26] responsible for leukocyte recruitment to sites of
inflammation, we would expect leukocyte recruitment to occur
through blood vessels nearest to these sites of damage.
Recently, we reported damage to airway epithelial cells in SH
rats repeatedly exposed to tobacco smoke for three months.
Damage was evidenced by apoptosis and neutrophil infiltration in
the bronchial wall with little apoptosis detected in the parenchyma
[27]. Moreover, repeated long-term smoke exposure causes SH rats
to develop epithelial squamous metaplasia, airway wall thickening
and airspace enlargement [28]. We now demonstrate that these
same rats have significant smoke-induced increases in neutrophils
present in the lungs compared to filtered air control rats.
It is possible that long-term smoke exposure may result in the
recruitment of neutrophils and other leukocytes through the
alveolar capillaries in the absence of enhanced adhesion molecules
and chemokines measured in this study. After 4 and 12 weeks of
tobacco smoke exposure, we observed signs of alveolar damage as
well as the presence of neutrophils within the lung parenchyma.
However, the majority of neutrophils observed for each time point
studied remained within the bronchial wall. VCAM and MIP-2
expression in the bronchial wall continued to be significantly
increased relative to controls, indicating that the bronchial
circulation remained a likely site of leukocyte emigration. Future
work is needed to determine the relative contribution, if any, of
leukocyte recruitment to the lung via the alveolar capillaries
during long-term smoke exposure.
Additionally, we found exposure to tobacco smoke for 3 days
and 4 weeks increased the number of bronchial blood vessels. It is
possible that increased vascularization further enhances recruit-
ment of leukocytes through the bronchial blood vessels. However,
Figure 6. Leukocytes recovered from the BALF of SH rats after 3 days, 4 weeks, or 12 weeks of tobacco smoke exposure. Total
leukocytes, monocyte/macrophages neutrophils, and lymphocytesrecovered from the BALF after 3 days, 4 weeks, or 12 weeks of tobacco smoke
exposure.
doi:10.1371/journal.pone.0033304.g006
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unlike adhesion molecule and chemokine expression, a causal
relationship between neovasculazation and leukocyte recruitment
has not been established. It is also possible that more bronchial
blood vessels are needed because of increased metabolic
requirements of the inflamed tissue.
This study further establishes the validity of repeated smoke
exposure in the SH rat as a viable model of chronic obstructive
lung disease by demonstrating similarities in the molecular
mechanisms of leukocyte recruitment observed in human COPD.
Repeated, intermittent exposure to tobacco smoke in SH rats can
serve as an excellent animal model of human chronic lung
inflammatory disease due to the fact SH rats possess many of the
characteristics found in human COPD, including sustained
recruitment of leukocytes to the lung with neutrophil infiltration
of the bronchial wall, bronchial epithelial cell apoptosis, airway
wall thickening, epithelial cell squamous metaplasia, goblet cell
hypertrophy and mucous hypersecretion. Increases in inflamma-
tory cytokines, oxidative stress, and protease activity have also
been demonstrated, as well as airspace enlargement [28,29].
Furthermore, in the work presented here, we demonstrate that E-
selectin, ICAM, MCP-1, and IL-8 homologue MIP-2 expression
are increased in the bronchial wall similar to that observed in
bronchial biopsies from patients with COPD [7–9,30].
These inflammatory and histopathological patterns noted in the
SH rat over time further demonstrate the utility of this model for
screening possible pharmaceuticals to treat COPD. Unlike other
rodent models found in the literature, we see chronic inflammatory
changes to the lung in as little as four weeks. It is now possible to
determine whether a drug is reducing leukocyte recruitment to the
lung by observing the effects of the drug on the adhesion molecules
and chemokines in or around the bronchial blood vessels.
While the SH model is able to produce inflammatory changes to
the lung that are similar to COPD in a short period of time, it
differs from COPD in a couple of ways. The SH rat model has a
very strong initial inflammatory cell recruitment that involves
mostly neutrophils and monocytes. After 12 weeks of smoke
exposure by SH rats, the ratio of inflammatory cells is still skewed
toward a neutrophilic response with a less pronounced adaptive
response compared to human COPD. Lymphocytes made up less
than 2% of the total cells. Lastly, whether the damage induced in
this model is reversible has not been tested.
In conclusion, tobacco smoke-induced lung inflammation is the
cause of most COPD cases. These findings have important
implications for understanding the etiology of COPD and suggest
that pharmaceuticals designed to reduce leukocyte recruitment
through the bronchial circulation may have promise as potential
therapy to treat COPD.
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